Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Impact of sharing Alzheimer's disease biomarkers with individuals without dementia: A systematic review and meta-analysis of empirical data.
Alzheimers Dement. 2023 Dec;19(12):5773-5794. doi: 10.1002/alz.13410. Epub 2023 Jul 26.
Alzheimers Dement. 2023.
PMID: 37496313
Review.
Dementia risk communication. A user manual for Brain Health Services-part 3 of 6.
Visser LNC, Minguillon C, Sánchez-Benavides G, Abramowicz M, Altomare D, Fauria K, Frisoni GB, Georges J, Ribaldi F, Scheltens P, van der Schaar J, Zwan M, van der Flier WM, Molinuevo JL.
Visser LNC, et al. Among authors: van der schaar j.
Alzheimers Res Ther. 2021 Oct 11;13(1):170. doi: 10.1186/s13195-021-00840-5.
Alzheimers Res Ther. 2021.
PMID: 34635169
Free PMC article.
Review.
Item in Clipboard
Considerations regarding a diagnosis of Alzheimer's disease before dementia: a systematic review.
van der Schaar J, Visser LNC, Bouwman FH, Ket JCF, Scheltens P, Bredenoord AL, van der Flier WM.
van der Schaar J, et al.
Alzheimers Res Ther. 2022 Feb 10;14(1):31. doi: 10.1186/s13195-022-00971-3.
Alzheimers Res Ther. 2022.
PMID: 35144684
Free PMC article.
Item in Clipboard
Stability of Furosemide 5 mg/mL in Polypropylene Syringes.
van der Schaar JAJ, Grouls R, Franssen EJF, Crul M.
van der Schaar JAJ, et al.
Int J Pharm Compd. 2019 Sep-Oct;23(5):414-417.
Int J Pharm Compd. 2019.
PMID: 31513540
Item in Clipboard
Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial.
Fruijtier AD, van der Schaar J, van Maurik IS, Zwan MD, Scheltens P, Bouwman F, Pijnenburg YAL, van Berckel BNM, Ebenau J, van der Flier WM, Smets EMA, Visser LNC.
Fruijtier AD, et al. Among authors: van der schaar j.
Alzheimers Dement. 2023 Jan;19(1):285-295. doi: 10.1002/alz.12630. Epub 2022 Apr 2.
Alzheimers Dement. 2023.
PMID: 35366050
Free PMC article.
Clinical Trial.
Item in Clipboard
Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study.
Waterink L, Masselink LA, van der Lee SJ, Visser LNC, Cleutjens S, van der Schaar J, van Harten AC, Scheltens P, Sikkes SAM, van der Flier WM, Zwan MD.
Waterink L, et al. Among authors: van der schaar j.
Alzheimers Res Ther. 2024 Jan 2;16(1):1. doi: 10.1186/s13195-023-01364-w.
Alzheimers Res Ther. 2024.
PMID: 38167083
Free PMC article.
Item in Clipboard
Toxicological screening in the Amsterdam acute setting becomes more relevant if the standard panel of the drugs-of-abuse point-of-care test is expanded with GHB and ketamine.
van der Schaar JAJ, Attema-de Jonge ME, Gresnigt FMJ, Franssen EJF.
van der Schaar JAJ, et al.
Toxicol Rep. 2020 Apr 20;7:539-546. doi: 10.1016/j.toxrep.2020.04.007. eCollection 2020.
Toxicol Rep. 2020.
PMID: 32368504
Free PMC article.
Item in Clipboard
Cite
Cite